Imerslund-Gräsbeck syndrome in a 25-month-old Italian girl caused by a homozygous mutation in AMN

Ital J Pediatr. 2013 Sep 17:39:58. doi: 10.1186/1824-7288-39-58.

Abstract

Imerslund-Gräsbeck syndrome is a rare autosomal recessive disorder, characterized by vitamin B12 deficiency due to selective malabsorption of the vitamin and usually results in megaloblastic anemia appearing in childhood. It is responsive to parenteral vitamin B12 therapy.The estimated prevalence (calculated based on Scandinavian data) is less than 6:1,000,000. However, many cases may be misdiagnosed.When there is reasonable evidence to suspect that a patient suffers from IGS, a new and straightforward approach to diagnosis is mutational analysis of the appropriate genes. We report for the first time the case of a girl of Italian ancestry with IGS genetically confirmed by the detection of a homozygous missense mutation in the AMN gene (c.208-2 A > G).

Publication types

  • Case Reports
  • Review

MeSH terms

  • Anemia, Megaloblastic
  • Child, Preschool
  • DNA Mutational Analysis
  • Female
  • Follow-Up Studies
  • Genetic Predisposition to Disease
  • Homozygote
  • Humans
  • Italy
  • Malabsorption Syndromes / diagnosis
  • Malabsorption Syndromes / drug therapy*
  • Malabsorption Syndromes / genetics*
  • Membrane Proteins
  • Mutation, Missense*
  • Proteins / genetics*
  • Proteinuria / diagnosis
  • Proteinuria / drug therapy*
  • Proteinuria / genetics*
  • Rare Diseases
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome
  • Vitamin B 12 / therapeutic use*
  • Vitamin B 12 Deficiency / diagnosis
  • Vitamin B 12 Deficiency / drug therapy*
  • Vitamin B 12 Deficiency / genetics*

Substances

  • AMN protein, human
  • Membrane Proteins
  • Proteins
  • Vitamin B 12

Supplementary concepts

  • Imerslund-Grasbeck syndrome